These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7972286)

  • 21. Differential effects of single and long-term amphetamine and apomorphine administrations on locomotor activity of rats.
    Bernardi MM; Scavone C; Frussa-Filho R
    Gen Pharmacol; 1986; 17(4):465-8. PubMed ID: 3758653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects on central dopamine function of chronic L-dopa (methyl ester hydrochloride) treatment of mice.
    Tabar J; Hashizume M; Cook CJ; Beart PM; Jackson DM
    Pharmacol Biochem Behav; 1989 May; 33(1):139-46. PubMed ID: 2789405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The locomotor and stereotype response to dopaminergic drugs and caffeine after intracerebroventricular kainic acid in rats.
    Kleinrok Z; Turski L; Wawrzyniak M; Cybulska R
    Pol J Pharmacol Pharm; 1981; 33(2):149-59. PubMed ID: 7198226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral evidence for supersensitivity after chronic bromocriptine administration.
    Smith RC; Strong JR; Hicks PB; Samorajski T
    Psychopharmacology (Berl); 1979 Feb; 60(3):241-6. PubMed ID: 108701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supersensitivity following repeated administration of dopaminergic agonists.
    Westermann KH
    Acta Physiol Pharmacol Bulg; 1982; 8(1-2):58-63. PubMed ID: 6889805
    [No Abstract]   [Full Text] [Related]  

  • 27. Behavioral responses to apomorphine and amphetamine in differentially housed mice.
    Wilmot CA; Vander Wende C; Spoerlein MT
    Psychopharmacology (Berl); 1984; 84(1):105-8. PubMed ID: 6436876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subthalamic responses to amphetamine and apomorphine in the behaving rat with a unilateral 6-OHDA lesion in the substantia nigra.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 1999 Dec; 34(3):228-40. PubMed ID: 10523760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in pre- and post-synaptic sensitivity to apomorphine between saline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57BL/6 mice as reflected in climbing activity.
    Spooren WP; Vassout A; Waldmeier P; Gentsch C
    Eur J Pharmacol; 1998 Jul; 353(1):1-4. PubMed ID: 9721033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral effects of amphetamine and apomorphine after striatal lesions in the rat.
    Antoniou K; Kafetzopoulos E
    Pharmacol Biochem Behav; 1992 Nov; 43(3):705-22. PubMed ID: 1448467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum.
    Kelly PH; Seviour PW; Iversen SD
    Brain Res; 1975 Sep; 94(3):507-22. PubMed ID: 1171714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of genotype in brain dopamine metabolism and dopamine-dependent behavior of mice.
    Skrinskaya JA; Nikulina EM; Popova NK
    Pharmacol Biochem Behav; 1992 Jun; 42(2):261-7. PubMed ID: 1385878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of the estrous cycle and estradiol on the behavioral effects of amphetamine and apomorphine in rats.
    Díaz-Véliz G; Baeza R; Benavente F; Dussaubat N; Mora S
    Pharmacol Biochem Behav; 1994 Dec; 49(4):819-25. PubMed ID: 7886093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopaminergic drugs antagonize the psychotomimetic effects of partial-agonist analgesics.
    Buckett WR; Shaw JS
    Psychopharmacologia; 1975 Jun; 42(3):293-7. PubMed ID: 1172254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased sensitivity to dopaminergic agonists after repeated electroconvulsive shock (ECS) in rats.
    Wielosz M
    Neuropharmacology; 1981 Oct; 20(10):941-5. PubMed ID: 7197762
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of systemic injections of dopaminergic agents on the habituation of rats submitted to an open field test.
    Furlan SM; Brandão ML
    Neuropsychobiology; 2001; 43(2):83-90. PubMed ID: 11174051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychotomimetics potentiate locomotor hyperactivity induced by dopaminergic drugs.
    Fink H; Morgenstern R; Oelssner W
    Pharmacol Biochem Behav; 1979 Nov; 11(5):479-82. PubMed ID: 531070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mechanographic method for measurement of locomotor activity in rats. Effects of dopaminergic drugs and electric stimulation of the brainstem.
    Johnels B; Steg G
    J Neurosci Methods; 1982 Jul; 6(1-2):17-27. PubMed ID: 7121058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of apomorphine and l-amphetamine-induced behaviors by magnesium.
    Kantak KM; Adlerstein LK
    Pharmacol Biochem Behav; 1990 May; 36(1):29-33. PubMed ID: 2349266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.